Ryman Healthcare Limited logo

Half year report provided

Half Year Results12 December 2019RYMHealthcare

Half Year Report 2019
RYMAN HEALTHCARE

Half year highlights
03

Key statistics

Financial statements

Report to shareholders

Our villages

Directory

04

07

12

26

28

RYMAN HEALTHCARE

2

Half year highlights
Our villages are home to

over 11,400 residents.

11, 4 0 0

residents

Total assets up 17.4% from

September 2018

$7.26

billion

Operating cash flows of

$256.1 million, up 17.6%

$256.1

million

Reported (IFRS)

profit up 11.1%

$188.3

million

We've invested $359.7 million in

new and exsiting villages.

$359.7

million

36 villages

We own and operate 36 retirement

villages in New Zealand and Australia

and have 18 new villages in the pipeline.

1984

Ryman Healthcare

was founded in 1984.

5,700

We employ over

5,700 staff.

7,074

7,074 beds and units in

our land bank.

Unaudited underlying profit up 6.2%

$103.0

million

*

*See key statistics for definition.

HALF YEAR REPORT 2019

3


30 Sept 2019

Six months


30 Sept 2018

Six months

31 March 2019

12 months

Financial

Underlying profit (non-GAAP)$m103.097.1227.0

Reported net profit after tax$m188.3169.5326.0

Net operating cash fl ows$m256.1217.8401.4

Net assets$m2,294.52,052.72,170.1

Total assets$m7,255.86,180.26,651.5

Interest-bearing debt to

interest-bearing debt plus

equity ratio%40%37%38%

Dividend per share

cents11.510.822.7

Villages

New sales of occupation rights

1

no.229168414

Resales of occupation rightsno.454405824

Total sales of occupation rightsno.6835731,238

Land bank (to be developed)

2,3,4

no.7,0746,0786,593

Portfolio:

Aged-care bedsno.3,6603,4483,660

Retirement-village unitsno.7,0716,6136,878

Total units and bedsno.10,73110,06110,538

Key statistics

FOR THE PERIOD ENDED 30 SEPTEMBER 2019

1 229 new sales of occupation rights for September 2019 includes 47 units rebuilt at Malvina Major.

2 Includes retirement-village units and aged-care beds.

3 Included in the 7,074 beds and units is a site acquisition at Northwood (Christchurch) which is subject

to Overseas Investment Office approval.

4 Of the 7,074 units and beds in the land bank, 3,428 are subject to resource and building consent.

4

RYMAN HEALTHCARE

Underlying profit is a non-GAAP* measure and diff ers from NZ IFRS profit for the period. Underlying profit
does not have a standardised meaning prescribed by GAAP and so may not be comparable to similar financial

information presented by other entities.

The Group uses underlying profit, with other measures, to measure performance. Underlying profit is a

measure that the Group uses consistently across reporting periods.

Underlying profit excludes deferred taxation, taxation expense, and unrealised gains on investment properties

because these items do not refl ect the trading performance of the Company. Underlying profit determines the

dividend payout to shareholders.

*Generally Accepted Accounting Principles


30 Sept 2019

Six months

30 Sept 2018

Six months

31 March 2019

12 months

Underlying profit (non-GAAP)$m103.097.1227.0

Plus unrealised gains on

retirement-village units$m92.772.8102.4

Less deferred tax movement$m(7.4)(0.4)(3.4)

Reported net profit after tax$m188.3169.5326.0

Key statistics

FOR THE PERIOD ENDED 30 SEPTEMBER 2019

HALF YEAR REPORT 2019

5

RYMAN HEALTHCARE
6

Report to shareholders
The team at Ryman Healthcare

has made good progress in the

first half, and we have a great deal

of momentum building to take us

into the months and years ahead.

Our unaudited first half underlying

profit rose 6.2 percent to

$103 million, driven by

record resales volumes.

As previously signalled, the second

half is expected to be stronger

as the build programme lifts,

and full year underlying profits

are expected to range from

$250 million to $265 million.

Reported (IFRS) profit, which

includes unrealised fair value gains

on investment property, increased

11.1 percent to $188.3 million.

Shareholders will receive an

increased interim dividend of

11.5 cents per share in line with

the increase in underlying profit.

The record date for entitlements

is December 6, and the dividend

will be paid on December 13.

Cash generation was strong in the

half, with operating cashfl ows up

17.6 percent to $256.1 million.

Our balance sheet strengthened

further during the half, with total

assets growing 17.4 percent

from September 2018 to

$7.26 billlion, refl ecting the value

created by ongoing development

and strong demand.

Full year profits are expected to

lift in line with growth in the build

programme, and construction

is targeted to be under way

at 12 sites by March 2020,

up from eight a year ago.

Our medium-term target remains

to double our underlying profi t

every fi ve years. This translates

to increasing our underlying profi t

by approximately 15 percent each

year. This target is unchanged,

and is, we believe, achievable.

Demand grows

in a tougher market

Our unique integrated villages

and high-quality care continued

to be in strong demand, with

care occupancy in established

villages running at 97 percent.

Only 1.6 percent of the retirement

village portfolio was available

for resale at September 30.

Resales volumes in New Zealand

grew 11.3 percent, while volumes

in the wider real estate market

declined 15 percent, which

demonstrated the continued

appeal of Ryman villages.

The first half result has been

achieved against a background

of tough market conditions in

Melbourne and Auckland, so we

are satisfied with the outcome.

HALF YEAR REPORT 2019

7

Our focus continued to be on
delivering new villages, innovating

to improve the experience of

living and working in a Ryman

community, and making sure

everyone got home safe each day.

Care at the heart

of everything we do

Our fundamental purpose is

to care for our residents as

well as we possibly can.

To do this we must constantly

innovate to improve the experience

of our residents whether they are

in care or living independently.

And we must work hard to ensure

that the team who deliver the care

have both the skills and resources

they need to do a great job, and

also that they love the experience

of being part of the Ryman family.

Our focus on excellence in care

continued in the half, and 84 percent

of our New Zealand care centres

now have four-year Ministry of

Health accreditation, compared to

an average of 47 percent among

large operators in the sector.

An example of our commitment

to investing in care is a program of

work we have named myRyman Life.

The myRyman Life Model of

Dementia Care programme is

designed to challenge and change

the perspectives on dementia

commonly held by staff , families

and residents.

Our aim is to build a supportive

and understanding community

network by demystifying dementia,

which allows our residents to live

life in the moment, feeling valued

and understood, and to give

them a sense of contentment.

We have more than 800 dementia

care beds and another 685

beds planned, which is a huge

commitment to dementia care.

Making sure our care and

consideration of the needs of

these people and their families

is the best it can be is what

myRyman Life is all about.

myRyman Life has brought together

everyone from across Ryman – from

architects and builders through

to our clinicians and contractors

– to reconsider how we improve

dementia design and care.

The programme is being introduced

through a range of education

resources to educate all staff ,

residents and their families using

up-to-date, research-based

methods which centre around our

core philosophy of kindness.

“Our fundamental

purpose is to care for

our residents as well as

we possibly can.”

RYMAN HEALTHCARE

8

More than 1,400 staff and 500
residents and family supporters

have already been trained in the

principles of myRyman Life.

What has been striking is the

level of support and interest

from families in the project.

They have been coming along

to the information sessions in

large numbers, which refl ects

that we are all on the same team

in working to provide the best

caring environment we can.

It is a project we are

enormously proud of.

In addition, we have signed up

as Alzheimers New Zealand’s

lead partner for the next three

years and more than 1,200 of

our Ryman staff have signed up

to become dementia friends.

We’ve also entered the

Alzheimers New Zealand

Dementia Friendly Programme.

We did all of this because we

back the mission to combat

stigma and to change hearts

and minds about dementia.

Improving the

resident experience

We continued to trial new ways

to improve the experience

of our residents who live

independently with us.

Ryman Delight is aimed at providing

additional activities which the

residents choose based on their

interests, in addition to the wide

range of activities we already provide.

The trial at each village is being run

by a concierge who arranges trips

to the theatre, concerts or sporting

events etc as well as weekends away.

In addition, we have introduced

village hosts in the evenings at

some of our larger villages.

The hosts provide bar snacks

and arrange movies and other

entertainment to make our village

centres more of a destination for

our residents and their friends

and families in the evenings.

We have also introduced an ECab

service for residents in four villages

and the low emission cabs have

been in demand, completing

500 trips with residents.

Investing in people

We continued to increase staff

pay in the half, to innovate in the

way we train, and to find ways to

identify talent and the leaders of

tomorrow and develop their careers.

“We continued to trial

new ways to improve

the experience of our

residents who live

independently with us.”

HALF YEAR REPORT 2019

9

We are about to send our first group
of senior leaders to Melbourne

Business School for the first of

four leadership modules.

This new Ryman Advanced

Leadership Programme has

been specially designed around

our culture and values, so that

we get better at developing and

leading more Rymanians.

Building to meet

our growth ambitions

We have significantly lifted our land

bank over the past three years

to match our growth aspirations

in New Zealand and Victoria.

We are now moving into our biggest

ever build programme on stunning

sites, which is exciting for the team

and our next generation of residents.

We acquired two new sites –

Highett in Victoria and Northwood

*


in Christchurch – during the

first half taking the land bank

to 7,074 units and beds.

The 22 sites in our land bank, 10 of

which already have development

under way, represent the equivalent

of 66 percent of our existing

portfolio. On development of

the existing land bank over the

coming years Ryman expects

to be providing homes and care

for more than 20,000 people.

We are targeting a build rate of 900

units and beds this year, up from

757 in the 2019 financial year.

A highlight of the half was

the progress in Victoria.

Our team exchanged a record

260 new sales, resales and care

contracts in the first half in Victoria.

We are interacting with more people

than ever and there is no doubt

our brand awareness is growing.

We have recently submitted our

tenth development application

in Victoria. Five development

approvals have been granted

already and we continue to

target having five villages open

in Victoria by the end of the

2020 calendar year.

As well as a record amount of

construction activity, we have

a whole lot of innovations feeding

through that will make life in a

Ryman village better than ever

for our residents.

We have had great feedback from

our residents and their families in

our recent surveys, and we continue

to strive to get even better.

Board strengthened

Our board has been further

strengthened with the appointment

of Melbourne-based director

Paula Jeff s. Paula is a human

resources executive with

experience across healthcare,

finance and government sectors.

*Subject to Overseas Investment Office approval.

RYMAN HEALTHCARE

10

We are a high growth business
and we know that finding and

developing the right sort of people

is critical to our success.

Paula brings great insight into people

and talent, and she will be a great

contributor. We have got a wealth

of talent and an excellent mix of

skills and diverse views on the board

which will see us into the future.

Thanks

We have a great team at Ryman.

The care, the kindness and the

professionalism they bring to work

each day is a credit to them.

Their dedication to the care and

wellbeing of our 11,400 residents

has allowed us to build a reputation

that is second to none.

We also regard you, our

shareholders, as part of our team.

We thank you for your support

which has allowed us to achieve

extraordinary things.

Since 1999 we have invested

$4 billion in building communities

and returned $860 million in

dividends. We have provided care,

comfort and security for more

than 30,000 people, and built an

extraordinary platform for growth.

We are moving into a record

expansion phase in the

next 18 months, but it is not

growth for growth’s sake.

It refl ects our mission to build as

many communities as we can so that

more people can benefit from the

Ryman experience. We regard it as

part of our social licence to do this.

We thank you for all your support

and enthusiasm for this mission.

We look forward to reporting

to you all in six months’ time on

more progress at Ryman.

Gordon MacLeod

CHIEF EXECUTIVE

RYMAN HEALTHCARE

Dr David Kerr

CHAIR

RYMAN HEALTHCARE

“We thank you for

all your support

and enthusiasm

for this mission.”

HALF YEAR REPORT 2019

11

Notes
Six months ended

30 Sept 2019

unaudited

Six months ended

30 Sept 2018

unaudited

Year ended

31 March 2019

audited

$000$000$000

Care fees163,093147,748302,003

Management fees43,91338,84078,944

Interest received230211532

Other income515391855

Total revenue207,751187,190382,334

Fair-value movement of

investment properties3180,009155,438292,910

Total income387,760342,628675,244

Operating expenses(168,729)(152,528)(303,745)

Depreciation and

amortisation expense(13,751)(11,250)(23,125)

Finance costs(9,557)(8,958)(18,959)

Total expenses(192,037)(172,736)(345,829)

Profit before income tax195,723169,892329,415

Income-tax expense(7,442)(359)(3,429)

Profit for the period188,281169,533325,986

Earnings per share

Basic and diluted

(cents per share) 37.733.965.2

All profit and total comprehensive income is attributable to parent company shareholders and is

derived from continuing operations.

The accompanying notes form part of these interim financial statements.

Consolidated income statement

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2019

12

RYMAN HEALTHCARE


Six months ended

30 Sept 2019

unaudited

Six months ended

30 Sept 2018

unaudited

Year ended

31 March 2019

audited

$000$000$000

Profit for the period188,281169,533325,986

Items that may be later

reclassified to profit or loss

Fair-value movement and

reclassification of interest-rate

swaps(7,479)(753)(5,181)

Deferred tax movement on

interest-rate swap reserve2,0942111,451

(Loss) / Gain on hedge of

foreign-owned subsidiary net

assets(2,471)(2,051)1,333

Gain / (Loss) on translation of

foreign operations

8,8395,375(4,966)

9832,782(7,363)

Items that may be later

reclassified to profit or loss

Revaluation of property, plant

and equipment (unrealised)

--

24,456

--

24,456

Other comprehensive income9832,78217,093

Total comprehensive income189,264172,315343,079

All profit and total comprehensive income is attributable to parent company shareholders and is

derived from continuing operations.

The accompanying notes form part of these interim financial statements.

Consolidated statement of comprehensive income

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2019

HALF YEAR REPORT 2019

13


Issued

capital

Asset

revaluation

reserve

Interest-

rate swap

reserve

Foreign-

currency

translation

reserve

Tr e a s u r y

stock

Retained

earnings

To t a l

equity

$000$000$000$000$000$000$000

Six months ended 30 Sept 2018 unaudited

Opening balance33,290233,319(5,913)(2,243)(22,497)

1,704,5631,940,519

Profit and total

comprehensive

income for the period

--(542)3,324-169,533172,315

Treasury stock

movement----(5,611)-(5,611)

Dividends paid to

shareholders-----(54,500)(54,500)

Closing balance at

30 Sept 201833,290233,319(6,455)1,081(28,108)

1,819,5962,052,723

Year ended 31 March 2019 audited

Opening balance33,290233,319(5,913)(2,243)(22,497)

1,704,5631,940,519

Profit and total

comprehensive

income for the year

-24,456(3,730)(3,633)-325,986343,079

Treasury stock

movement----(4,968)-(4,968)

Dividends paid to

shareholders-----(108,500) (108,500)

Closing balance at

31 March 201933,290257,775(9,643)(5,876)(27,465)

1,922,0492,170,130

Six months ended 30 Sept 2019 unaudited

Opening balance33,290257,775(9,643)(5,876)(27,465)

1,922,0492,170,130

Profit and total

comprehensive

income for the period

--(5,385)6,368-188,281189,264

Treasury stock

movement----(5,413)-(5,413)

Dividends paid to

shareholders-----(59,500)(59,500)

Closing balance at

30 Sept 201933,290257,775(15,028)492(32,878)

2,050,8302,294,481

The accompanying notes form part of these interim financial statements.

Consolidated statement of changes in equity

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2019

14

RYMAN HEALTHCARE

Notes
30 Sept 2019

unaudited

30 Sept 2018

unaudited

31 March 2019

audited

$000$000$000

Assets

Trade and other receivables332,792298,880344,814

Advances to employees10,9968,5248,152

Property, plant and equipment1,456,1811,093,7171,188,940

Investment properties35,423,8134,754,4795,081,607

Intangible assets32,00824,57427,968

Total assets7,255,7906,180,1746,651,481

Equity

Issued capital633,29033,29033,290

Asset revaluation reserve257,775233,319257,775

Interest-rate swap reserve(15,028)(6,455)(9,643)

Foreign-currency translation

reserve4921,081(5,876)

Treasury stock(32,878)(28,108)(27,465)

Retained earnings2,050,8301,819,5961,922,049

Total equity2,294,4812,052,7232,170,130

Liabilities

Trade and other payables7181,64876,990126,909

Employee entitlements25,47122,60723,834

Revenue in advance60,81755,07157,845

Interest-rate swaps20,8728,96513,393

Refundable accommodation

deposits61,78831,18934,013

Bank loans (secured)1,505,0121,214,3371,324,003

Occupancy advances

(non-interest bearing)43,015,6352,646,4582,827,690

Lease liabilities11,297--

Deferred tax liability (net)78,76971,83473,664

Total liabilities4,961,3094,127,4514,481,351

Total equity and liabilities7,255,7906,180,1746,651,481

Net tangible assets

Basic and diluted

(cents per share)452.5405.6428.4

The accompanying notes form part of these interim financial statements.

Consolidated balance sheet

AT 30 SEPTEMBER 2019

HALF YEAR REPORT 2019

15

Notes
Six months ended

30 Sept 2019

unaudited

Six months ended

30 Sept 2018

unaudited

Year ended

31 March 2019

audited

$000$000$000

Operating activities

Receipts from residents582,834518,2671,009,496

Interest received177265588

Payments to suppliers and

employees(166,583)(149,785)(306,234)

Payments to residents(150,800)(145,286)(283,736)

Interest paid(9,557)(5,624)(18,689)

Net operating cash fl ows 2256,071217,837401,425

Investing activities

Purchase of property, plant

and equipment(197,778)(104,564)(150,252)

Purchase of intangible assets(3,819)(3,060)(6,918)

Purchase of investment

properties(140,922)(181,546)(364,186)

Capitalised interest paid(17,230)(14,775)(31,003)

Advances to employees(2,843)(2,688)(2,316)

Net investing cash fl ows(362,592)(306,633)(554,675)

Financing activities

Drawdown of bank loans (net)172,268148,907266,718

Dividends paid(59,500)(54,500)(108,500)

Purchase of treasury stock (net)(5,414)(5,611)(4,968)

Repayment of lease liabilities(833)--

Net financing cash fl ows106,52188,796153,250

Net increase in cash and

cash equivalents---

Cash and cash equivalents at

the beginning of the period---

Cash and cash equivalents

at the end of the period---

The accompanying notes form part of these interim financial statements.

Consolidated statement of cash fl ows

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2019

16

RYMAN HEALTHCARE

STATEMENT OF COMPLIANCE
The financial statements presented are those

of Ryman Healthcare Limited (the Company),

and its subsidiaries (the Group). Ryman

Healthcare Limited is a profit-oriented entity

incorporated in New Zealand that develops,

owns, and operates integrated retirement

villages, resthomes, and hospitals for the elderly

within New Zealand and Australia.

Ryman Healthcare Limited is a Financial

Markets Conduct Act reporting entity under the

Financial Reporting Act 2013 and the Financial

Markets Conduct Act 2013. Its financial

statements comply with these Acts.

The unaudited condensed consolidated interim

financial statements have been prepared in line

with Generally Accepted Accounting Principles

in New Zealand (NZ GAAP). The statements

comply with New Zealand equivalents to

International Accounting Standard 34

(NZ IAS 34) Interim Financial Reporting and

International Accounting Standard 34 (IAS 34)

Interim Financial Reporting.

BASIS OF PREPARATION

The financial statements for the six

months ended 30 September 2019 and the

comparative six months ended 30 September

2018 are unaudited.

Apart from the new standards adopted in

the current period (see below), these financial

statements have been prepared under the

same accounting policies and methods as

the Company’s Annual Report at 31 March 2019.

These financial statements should

be read in conjunction with the financial

statements and related notes included in the

Company’s Annual Report for the year ended

31 March 2019.

The financial statements were approved by the

Board of Directors on 20 November 2019.

The information is presented in thousands

of New Zealand dollars.

All references to AUD refer to Australian dollars.

1. SUMMARY OF SIGNIFICANT

ACCOUNTING POLICIES

Adoption of new and revised standards

and interpretations

In the current period the Group adopted

all mandatory new and amended standards

and interpretations.

During the period, NZ IFRS 16 Leases has been

adopted with eff ect from 1 April 2019. The new

standard introduces a single lessee accounting

model that brings all leases on balance sheet

except low-value or short-term leases (less than

a year). Adopting the standard has not had a

material impact on the financial statements.

The Group has chosen to adopt the modified

retrospective approach to transition.

Comparative periods presented have

not been restated.

Operating leases that were previously

off balance sheet are now included on the

balance sheet under NZ IFRS 16 through

the recognition of right-of-use assets and

associated liabilities. Rental and operating

lease expenses previously recognised within

other operating expenses are now recognised

as depreciation for right-of-use assets and

finance costs for lease liabilities in the income

statement. In the statement of cash fl ows,

operating lease payments previously classified

as cash fl ows from operating activities are now

classified as cash fl ows from financing activities

for principal repayments of the lease liability

and cash fl ows from operating activities for the

interest payments. There has been no impact

on actual cash payments as a result of the

adoption of NZ IFRS 16.

Notes to the consolidated interim financial statements

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2019

HALF YEAR REPORT 2019

17

The Group used a number of practical
expedients when applying NZ IFRS 16 to

leases previously classified as operating

leases. In particular, the Group:

• did not recognise right-of-use assets

and liabilities for leases for which the lease

term ends within 12 months of the date of

initial application

• did not recognise right-of-use assets and

liabilities for leases of low-value assets

(for example, IT equipment)

• excluded initial direct costs from the

measurement of the right-of-use asset

at the date of initial application

• applied a single discount rate to portfolios

of leases with similar characteristics

• used hindsight when determining the

lease term

Right-of-use assets are measured at an

amount equal to the lease liability, adjusted by

the amount of any prepaid or accrued lease

payments. Following the adoption of NZ IFRS

16 the group has presented right-of use assets

within ‘property, plant and equipment’.

The group leases office buildings, sales offices,

office equipment (for example, photocopiers),

and plant and equipment for the use in the

construction of retirement-village units and

aged-care beds. After using the available

recognition exemptions allowed in NZ IFRS 16

for short-term leases and leases of low-value

assets it is only the Group’s lease of office

premises, sales offices and tower cranes for

which right of use assets and lease liabilities

have been recognised under the new standard.

The expenses incurred for short-term and

low-value leases continue to be recognised on a

straight-line basis in the income statement.

The Group recognises all long-term lease of

land within property, plant and equipment and

investment property. There has been no impact

on how the leases have been accounted for

under NZ IFRS 16 other than the recognition of

any future lease payments required under the

terms of the contract.

A lease contract may contain both lease and

non-lease components. For construction

leases (for example, scaff olding and tower

cranes), the Group has elected not to

separate non-lease components from lease

components, and instead accounts for the

whole contract as a lease.

As a result of adopting the new standard the

Group recognised $13.4 million of right-of-use

assets and associated lease liability in the

balance sheet at 1 April 2019.

At 30 September 2019, the right-of-use asset

was $11.1 million and the lease liability was

$11.3 million. The profit for the six months to

30 September 2019 is $0.2 million lower than

the profit that would have been reported had

the standard not been in place. This comprises

a decrease in operating expenses of $0.8

million, an increase in depreciation expense of

$0.8 million and an increase in finance costs

of $0.2 million. Net operating cash fl ows have

increased by $0.8 million and net financing

cash fl ows have decreased by $0.8 million

because of the adoption of the standard.

When measuring lease liabilities, the Group

discounts lease payments using its incremental

borrowing rate. This is calculated with reference

to the external borrowing facilities available to

the Group and the specific characteristics of

the lease. The weighted average borrowing rate

for the Group is 3.75%.

The depreciation and finance costs associated

with the right-of-use asset and lease liability

for tower cranes is capitalised as a cost of

constructing the asset.

For leases where the Group is the lessor

there has been no change to the recognition

or measurement on adoption of NZ IFRS 16.

There is no change in how occupation-right

agreements and associated management

fees are recognised. Management fees are

recognised on a straight-line basis over the

period of service. The period is determined

as being the greater of the expected period

of tenure, or the contractual right to

management fees.

Notes to the consolidated interim financial statements

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2019

18

RYMAN HEALTHCARE


Six months ended

30 Sept 2019

unaudited

Six months ended

30 Sept 2018

unaudited

Year ended

31 March 2019

audited

$000$000$000

Net profit after tax188,281169,533325,986

Adjusted for:

Movements in

balance-sheet items

Occupancy advances223,837157,615367,538

Accrued management fees(35,271)(25,417)(54,652)

Refundable accommodation

deposits

27,7754323,256

Revenue in advance2,9723,1165,890

Trade and other payables676(271)2,165

Trade and other receivables12,02258,60312,669

Employee entitlements1,6372,3703,597

Non-cash items:

Depreciation and amortisation13,75111,25023,125

Deferred tax7,4423593,429

Unrealised foreign-exchange loss(7,042)(4,315)1,332

Adjusted for:

Fair-value movement of

investment properties

(180,009)(155,438)(292,910)

Net operating cash fl ows256,071217,837401,425

Net operating cash fl ows include occupancy advance receipts from retirement village residents

of $393.5 million (six months ended 30 September 2018: $370.6 million and year ended 31 March

2019: $703.6 million).

Also included in operating cash fl ows are net receipts from refundable accommodation deposits of

$26.6 million (six months ended 30 September 2018: net payments of $0.4 million and year ended

31 March 2019: net receipts of $3.8 million).

Net operating cash fl ows also include management fees collected of $21.2 million (six months

ended 30 September 2018: $20.2 million and year ended 31 March 2019: $39.0 million).

Notes to the consolidated interim financial statements

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2019

2. RECONCILIATION OF NET PROFIT AFTER TAX FOR THE PERIOD

WITH NET CASH FLOW FROM OPERATING ACTIVITIES

HALF YEAR REPORT 2019

19


Six months ended

30 Sept 2019

unaudited

Six months ended

30 Sept 2018

unaudited

Year ended

31 March 2019

audited

$000$000$000

At fair value

Balance at beginning of

financial period5,081,6074,398,3044,398,304

Additions147,316192,213395,931

Fair-value movement:

Realised fair-value movement:

• new retirement-village units31,83532,85087,866

• existing retirement-village units55,49349,762102,600

87,32882,612190,466

Unrealised fair-value movement92,68172,826102,444

180,009155,438292,910

Net foreign-currency

exchange diff erences14,8818,524(5,538)

Net movement for period342,206356,175683,303

Balance at end of financial period5,423,8134,754,4795,081,607

The realised fair-value movement arises from the sale and resale of occupancy advances to residents.

Investment properties are not depreciated and are fair valued.

The carrying value of completed investment property is the fair value as determined by an

independent valuation report prepared by registered valuers CBRE Limited, at 30 September 2019.

The valuer used significant assumptions that include long-term house-price infl ation (ranging from 0

percent to 3.5 percent nominal) (30 September 2018 and 31 March 2019: 0.5 percent to 3.5 percent)

and discount rate (ranging from 12 percent to 16 percent) (30 September 2018: 12 percent to 16.5

percent and 31 March 2019: 12 percent to 16 percent).

Investment property includes investment property work in progress of $318.9 million (six months

ended 30 September 2018: $329.0 million and year ended 31 March 2019: $325.1 million), which has

been valued at cost.

The CBRE valuation for the six months ended 30 September 2018 included within its forecast cash

fl ows the Group's expected costs relating to rebuild works at Malvina Major. The estimate of the gross

cash outfl ows included for remediation works was $10 million over a remaining 6-month period. (31

March 2019: $6 million over a remaining 6-month period). The estimates were based on information

available at the time. No costs have been included in the six months ended 30 September 2019.

Notes to the consolidated interim financial statements

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2019

3. INVESTMENT PROPERTIES

20

RYMAN HEALTHCARE


Six months ended

30 Sept 2019

unaudited

Six months ended

30 Sept 2018

unaudited

Year ended

31 March 2019

audited

$000$000$000

Gross occupancy advances

(see below)3,427,6882,993,9293,203,851

Less management fees and

resident loans(412,053)(347,471)(376,161)

Closing balance3,015,6352,646,4582,827,690

Movement in gross

occupancy advances

Opening balance3,203,8512,836,3142,836,314

Plus net increases in

occupancy advances:

• new retirement-village units160,726120,447290,701

• existing retirement-village

units55,49349,762102,600

Net foreign-currency

exchange diff erences8,7665,245(3,408)

Decrease in occupancy

advance receivables(1,148)(17,839)(22,356)

Closing balance3,427,6882,993,9293,203,851

Gross occupancy advances are non-interest bearing.

Notes to the consolidated interim financial statements

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2019

4. OCCUPANCY ADVANCES (NON-INTEREST BEARING)

HALF YEAR REPORT 2019

21

5. DIVIDEND
On 21 November 2019 an interim dividend of 11.5 cents per share was declared and will be

paid on 13 December 2019 (prior year: 10.8 cents per share). The record date for entitlements

is 6 December 2019.

6. SHARE CAPITAL

Issued and paid-up capital consists of 500,000,000 fully paid ordinary shares

(30 September 2018: 500,000,000 and 31 March 2019: 500,000,000). All shares rank

equally in all respects.

Basic and diluted earnings and net tangible assets per share have been calculated on

the basis of 500,000,000 ordinary shares (30 September 2018: 500,000,000 and

31 March 2019: 500,000,000 shares).

Shares purchased on market under the leadership share scheme are treated as treasury stock

until vesting to the employee.

7. TRADE AND OTHER PAYABLES

Trade payables are typically paid within 30 days of invoice date or the 20th of the month

following the invoice date. Other payables at 30 September 2019 includes $105.4 million

(30 September 2018: $19.6 million and 31 March 2019: $68.1 million) for the purchase of land.

Notes to the consolidated interim financial statements

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2019

22

RYMAN HEALTHCARE

New ZealandAustraliaGroup
$000$000$000

Six months ended 30 Sept

2019 unaudited

Revenue194,81712,934207,751

Underlying profit (non-GAAP)92,81210,230103,042

less deferred tax expense(19,804)12,362(7,442)

plus unrealised fair-value

movement79,35213,32992,681

Profit for the period152,36035,921188,281

Non-current assets6,016,085895,9176,912,002

Six months ended 30 Sept

2018 unaudited

Revenue176,87210,318187,190

Underlying profit (non-GAAP)75,65921,40797,066

less deferred tax expense(359)-(359)

plus unrealised fair-value

movement60,70112,12572,826

Profit for the period136,00133,532169,533

Non-current assets5,237,233635,5375,872,770

Notes to the consolidated interim financial statements

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2019

8. OPERATING SEGMENTS

The Ryman Group operates in one industry, being the provision of integrated retirement villages for

older people in New Zealand and Australia. In presenting information on the basis of geographical

areas, net profit, underlying profit, and revenue are based on the geographical location of

operations. Assets are based on the geographical location of the assets.

HALF YEAR REPORT 2019

23

Underlying profit is a non-GAAP measure and diff ers from NZ IFRS profit for the period. Underlying
profit does not have a standardised meaning prescribed by GAAP and so may not be comparable

to similar financial information presented by other entities. The Group uses underlying profit, with

other measures, to measure performance. Underlying profit is a measure that the Group uses

consistently across reporting periods.

Underlying profit excludes deferred taxation, taxation expense, and unrealised gains on investment

properties because these items do not refl ect the trading performance of the Company. Underlying

profit determines the dividend payout to shareholders.

9. COMMITMENTS

The Group had commitments relating to construction contracts amounting to $147.4 million at 30

September 2019 (30 September 2018: $129.9 million and 31 March 2019: $127.3 million).

10. SUBSEQUENT EVENTS

Other than the dividends in note 5, there are no subsequent events.

New ZealandAustraliaGroup

$000$000$000

Year ended 31 March 2019

audited

Revenue358,52423,810382,334

Underlying profit (non-GAAP)189,90337,068226,971

less deferred tax expense(3,429)-(3,429)

plus unrealised fair-value

movement90,16712,277102,444

Profit for the year276,64149,345325,986

Non-current assets5,598,182700,3336,298,515

Notes to the consolidated interim financial statements

FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2019

8. OPERATING SEGMENTS (CONTINUED)

24

RYMAN HEALTHCARE

HALF YEAR REPORT 2019
25

Highton1
Mt Martha

1

Mt Eliza

1

Aberfeldie

1

Coburg

Highett

Weary Dunlop

1

Nellie Melba

1

Ringwood East


Aberfeldie


Burwood East


Coburg


Highett


Highton


Mt Eliza


Mt Martha


Nellie Melba


Ocean Grove


Ringwood East


Weary Dunlop

Our villages in Victoria, Australia

Our villages in New Zealand

Whangarei


Jane Mander

Auckland


Bert Sutcliff e


Bruce McLaren


Edmund Hillary


Evelyn Page


Grace Joel


Hobsonville


Kohimarama


Lincoln Road


Logan Campbell


Murray Halberg


Possum Bourne


William Sanders

Hamilton


Hilda Ross


Linda Jones

Tauranga


Bob Owens

Gisborne


Kiri Te Kanawa

New Plymouth


Jean Sandel

Napier


Princess Alexandra

Havelock North


Te A u t e R o a d

Whanganui


Jane Winstone

Palmerston

North


Julia Wallace

Waikanae


Charles Fleming

Wellington


Bob Scott


Karori


Malvina Major


Newtown


Rita Angus


Shona McFarlane

Nelson


Ernest Rutherford

Rangiora


Charles Upham

Christchurch


Anthony Wilding


Diana Isaac


Essie Summers


Margaret Stoddart


Ngaio Marsh


Northwood*


Park Terrace


Riccarton Park


Woodcote

Dunedin


Frances Hodgkins


Yvette Williams

Invercargill


Rowena Jackson

Ocean Grove

Burwood East

1

1

1

1

1

Ryman village

Under construction

Council approval

Proposed village

*Subject to Overseas Investment Office approval

26

RYMAN HEALTHCARE

Our villages
Invercargill

1

Dunedin

Rangiora1

Christchurch

63

Nelson

1

Wellington

42

Waikanae

1

Palmerston North

1

Whanganui

1

New Plymouth

1

Havelock North

1

Napier

1

Gisborne

1

Tauranga1

Hamilton

2

Whangarei

1

Auckland

9

2

11

1

HALF YEAR REPORT 2019

27

Retirement villages
Anthony Wilding Retirement Village

5 Corbett Crescent, Aidanfield,

Christchurch

Bert Sutcliff e Retirement Village

2 Rangatira Road, Birkenhead, Auckland

Bob Owens Retirement Village

112 Carmichael Road, Bethlehem, Tauranga

Bob Scott Retirement Village

25 Graham Street, Petone, Lower Hutt

Bruce McLaren Retirement Village

795 Chapel Road, Howick, Auckland

Charles Fleming Retirement Village

112 Parata Street, Waikanae

Charles Upham Retirement Village

24 Charles Upham Drive, Rangiora

Diana Isaac Retirement Village

1 Lady Isaac Way, Mairehau, Christchurch

Edmund Hillary Retirement Village

221 Abbotts Way, Remuera, Auckland

Ernest Rutherford Retirement Village

49 Covent Drive, Stoke, Nelson

Essie Summers Retirement Village

222 Colombo Street, Beckenham,

Christchurch

Evelyn Page Retirement Village

30 Ambassador Glade, Orewa, Auckland

Frances Hodgkins Retirement Village

40 Fenton Crescent, St Clair, Dunedin

Grace Joel Retirement Village

184 St Heliers Bay Road, St Heliers,

Auckland

Hilda Ross Retirement Village

30 Ruakura Road, Hamilton

Jane Mander Retirement Village

262 Fairway Drive, Kamo, Whangarei

Jane Winstone Retirement Village

49 Oakland Avenue, St Johns Hill,

Whanganui

Jean Sandel Retirement Village

71 Barrett Road, New Plymouth

Directory

REGISTERED OFFICE

Airport Business Park

92 Russley Road, Christchurch

PO Box 771, Christchurch 8042

New Zealand

MELBOURNE OFFICE

Suite 10.03, Level 10

420 St Kilda Road, Melbourne

PO Box 33119

Melbourne VIC 3004, Australia

28

RYMAN HEALTHCARE

SHARE REGISTRAR
Link Market Services

PO Box 91976, Auckland 1142

New Zealand

P: +64 9 375 5998

E: enquiries@linkmarketservices.com

AUCKLAND OFFICE

93 Ascot Avenue, Remuera

Auckland 1051, New Zealand

Julia Wallace Retirement Village

28 Dogwood Way, Clearview Park,

Palmerston North

Kiri Te Kanawa Retirement Village

12 Gwyneth Place, Lytton West, Gisborne

Linda Jones Retirement Village

1775 River Road, Hamilton

Logan Campbell Retirement Village

187 Campbell Road, Greenlane, Auckland

Malvina Major Retirement Village

134 Burma Road, Khandallah, Wellington

Margaret Stoddart Retirement Village

23 Bartlett Street, Riccarton, Christchurch

Murray Halberg Retirement Village

11 Commodore Drive, Lynfield, Auckland

Nellie Melba Retirement Village

2 Collegium Avenue, Wheelers Hill,

Melbourne

Ngaio Marsh Retirement Village

95 Grants Road, Papanui, Christchurch

Possum Bourne Retirement Village

5 Lisle Farm Drive, Pukekohe

Princess Alexandra Retirement Village

145 Battery Road, Napier

Rita Angus Retirement Village

66 Coutts Street, Kilbirnie, Wellington

Rowena Jackson Retirement Village

40 O’Byrne Street North, Waikiwi,

Invercargill

Shona McFarlane Retirement Village

66 Mabey Road, Lower Hutt

Weary Dunlop Retirement Village

242 Jells Road, Wheelers Hill, Melbourne

William Sanders Retirement Village

7 Ngataringa Road, Devonport, Auckland

Woodcote Retirement Village

29 Woodcote Avenue, Hornby, Christchurch

Yvette Williams Retirement Village

383 Highgate, Roslyn, Dunedin

HALF YEAR REPORT 2019

29

New villages in the pipeline
Victoria

Aberfeldie

2 Vida Street, Aberfeldie, Melbourne

Burwood East

65 Old Burwood Road, Burwood East,

Melbourne

Coburg

81a Bell Street, Coburg, Melbourne

Highett

32-40 Graham Road, Highett, Melbourne

Highton

157 South Valley Road, Highton, Victoria

Mt Eliza

70 Kunyung Road, Mt Eliza, Melbourne

Mt Martha

180 Bentons Road, Mt Martha, Melbourne

Ocean Grove

181 -199 Shell Road, Ocean Grove, Victoria

Ringwood East

2-16 Mt Dangdenong Road, Ringwood East,

Melbourne

New Zealand

Havelock North

122 Te Aute Road, Havelock North

Hobsonville

3 Scott Road, Hobsonville, Auckland

Karori

26 Donald Street, Karori, Wellington

Kohimarama

223 Kohimarama Road, Kohimarama,

Auckland

Lincoln Road

211 Lincoln Road, Henderson, Auckland

Newtown

192-206 Adelaide Road, Newtown,

Wellington

Northwood

486 Main North Road, Northwood,

Christchurch

Park Terrace

78 & 100 Park Terrace, Christchurch

Riccarton Park

1 Steadman Road, Christchurch

For more information on any of Ryman Healthcare’s retirement villages:

(New Zealand) 0800 588 222

rymanhealthcare.co.nz

(Australia) 1800 922 988

rymanhealthcare.com.au

Directory

30

RYMAN HEALTHCARE

rymanhealthcare.co.nz
rymanhealthcare.com.au

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.